Riskpilot← Back to searchSign inGet full accessSnabbvaccin Sverige AB
ABBankruptOrg 5593043879General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2023
SEK 25,4M
+137% vs 2022
EBITDA margin
5.5%
-50% vs 2022
Equity ratio
13.9%
Financial strength
Net profit 2023
SEK 780K
-53% vs 2022
| Revenue | SEK 25,4M | +137% |
| EBITDA | SEK 1,4M | -50% |
| Net profit | SEK 780K | -53% |
| Total assets | SEK 17,7M | +291% |
| Equity | SEK 2,5M | +46% |
| Employees | 0 | — |
Legal name
Snabbvaccin Sverige AB
Org number
5593043879
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 mars 2021
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva hälso- och sjukvård med huvudinriktning på försäljning och utgivande av vaccinationer i kliniker och vaccinationsbussar.
Address
Email
info@snabbvaccin.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 |
|---|---|---|
| Revenue | 10 716 | 25 440 |
| Staff expenses | −1 239 | −5 907 |
| EBITDA | 2 812 | 1 399 |
| Depreciation & amort. | −32 | −551 |
| EBIT | 2 780 | 849 |
| Net financials | −5 | −177 |
| Profit before tax | 2 086 | 1 361 |
| Tax | −431 | −581 |
| Net profit | 1 654 | 780 |
| Item | 2022 | 2023 |
|---|---|---|
| Total assets | 4 518 | 17 666 |
| Equity | 1 679 | 2 460 |
| Long-term debt | — | 9 935 |
| Short-term debt | 2 148 | 5 271 |
| Total debt | 2 148 | 15 206 |
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
20222023
Equity ratio
13.9%
This company
38.2%
Market median
-64% vs market
20222023
Return on equity
31.7%
This company
18.4%
Market median
+72% vs market
20222023
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20222023
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
20222023
Debt / equity
6.18×
This company
0.62×
Market median
-897% vs market
20222023
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
EA | Audit | 2024 – 2025 |
HA Chief Executive Officer | Chief Executive Officer | 2024 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Former (7) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Chairman | 2022 – 2025 | |
| Deputy Board Member | 2021 – 2025 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2024 | |
| Deputy Board Member | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skancia Group AB
Snabbvaccin Sverige AB Board members of Snabbvaccin Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Arne Peter Sandberg | Audit | 0 companies |
| Hossein Allahyari | Chief Executive Officer | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Reza Allahyari | Deputy Board Member | 0 companies |
| Alexis Dante De La Cuadra | Chairman | 0 companies |
| Karoline Susanna Anitha Wallgren | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Mahmoud Allahyari | Board of Directors | 0 companies |
| Hussein Jabbari | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |